F. Duca

发表

Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy

P. Elliott, C. Rapezzi, S. Dorbala, 2021, European Journal of Heart Failure.

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding

C. Hengstenberg, A. Agibetov, L. Koller, 2019, Journal of clinical medicine.

Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction.

C. Hengstenberg, A. Agibetov, J. Mascherbauer, 2019, Hypertension.

Renin Feedback Is an Independent Predictor of Outcome in HFpEF

D. Bonderman, C. Binder, F. Duca, 2021, Journal of personalized medicine.

Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation.

C. Hengstenberg, C. Loewe, D. Beitzke, 2019, JACC. Cardiovascular imaging.

Syncope: The Underestimated Threat in Severe Aortic Stenosis.

C. Hengstenberg, G. Laufer, J. Mascherbauer, 2019, JACC. Cardiovascular imaging.

Syncope: The Underestimated Threat in Severe Aortic Stenosis.

C. Hengstenberg, G. Laufer, J. Mascherbauer, 2019, JACC. Cardiovascular imaging.

Hemodynamic Profiles and Their Prognostic Relevance in Cardiac Amyloidosis

C. Hengstenberg, J. Mascherbauer, H. Agis, 2020, Journal of clinical medicine.

Bioimpedance Spectroscopy Reveals Important Association of Fluid Status and T1 ‐Mapping by Cardiovascular Magnetic Resonance

C. Loewe, D. Beitzke, Matthias Schneider, 2022, Journal of magnetic resonance imaging : JMRI.

Diameter of the Pulmonary Artery in Relation to the Ascending Aorta: Association with Cardiovascular Outcome.

Matthias Schneider, J. Mascherbauer, D. Bonderman, 2017, Radiology.

Sex Differences in Left Ventricular Remodeling and Outcomes in Chronic Aortic Regurgitation

C. Hengstenberg, U. Hoffmann, C. Loewe, 2020, Journal of clinical medicine.

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling

J. Mascherbauer, D. Bonderman, C. Binder, 2017, Wiener klinische Wochenschrift.

Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?

M. Hacker, S. Rasul, D. Bonderman, 2022, Journal of Nuclear Cardiology.

Diagnosis and supportive therapeutic management of cardiac light chain amyloidosis—a cardiologist’s perspective

C. Binder, F. Duca, Christina Binder, 2021, memo - Magazine of European Medical Oncology.

In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR)

C. Loewe, M. Hacker, S. Rasul, 2020, Journal of clinical medicine.

Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair.

M. Hacker, M. Fontana, J. Mascherbauer, 2022, JACC. Cardiovascular interventions.

Low serum potassium levels and diabetes - An unfavorable combination in patients with heart failure and preserved ejection fraction.

D. Bonderman, C. Binder, F. Duca, 2020, International journal of cardiology.

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial

C. Binder-Rodriguez, E. Grünig, R. Steringer-Mascherbauer, 2022, European heart journal.

Global Longitudinal Strain by CMR Feature Tracking Is Associated With Outcome in HFPEF.

C. Hengstenberg, C. Loewe, J. Mascherbauer, 2019, JACC. Cardiovascular imaging.

Riociguat for the treatment of transthyretin cardiac amyloidosis: data from a named patient use program in Austria

J. Mascherbauer, H. Agis, R. Kain, 2019, Pulmonary circulation.

336Left atrial function in heart failure with preserved ejection fraction: backward and forward coupling and prognostic relevance

C. Hengstenberg, C. Loewe, J. Mascherbauer, 2019, European Heart Journal - Cardiovascular Imaging.

Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome

C. Loewe, A. Geppert, M. Hacker, 2020, European journal of heart failure.

Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc Analysis

C. Loewe, M. Trauner, D. Beitzke, 2022, Circulation. Cardiovascular imaging.

Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy

D. Bonderman, C. Binder, F. Duca, 2022, Circulation. Heart failure.

Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study

J. Mascherbauer, D. Bonderman, S. Aschauer, 2016, Circulation. Cardiovascular imaging.

Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis.

C. Hengstenberg, C. Loewe, J. Mascherbauer, 2017, JACC. Cardiovascular imaging.

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death

F. Frommlet, D. Bonderman, C. Binder, 2022, Frontiers in Cardiovascular Medicine.

Mechanisms of heart failure in transthyretin vs. light chain amyloidosis.

C. Hengstenberg, T. Binder, J. Mascherbauer, 2019, European heart journal cardiovascular Imaging.

Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots

F. Zimprich, W. Löscher, C. Beetz, 2020, Journal of clinical medicine.

Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy

D. Bonderman, C. Binder, F. Duca, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.

A. Greiser, S. Pfaffenberger, J. Mascherbauer, 2016, JACC. Cardiovascular imaging.

Impact of Left Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Insights From Cardiac Magnetic Resonance Feature Tracking.

C. Hengstenberg, C. Loewe, J. Mascherbauer, 2020, JACC. Cardiovascular imaging.

Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study

G. Poelzl, C. Ebner, N. Verheyen, 2022, Biomedicines.

Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction

C. Hengstenberg, J. Mascherbauer, D. Bonderman, 2019, Scientific Reports.

Development and validation of a TTR-specific copy number screening tool, and application to potentially relevant patient cohorts.

C. Beetz, J. Mascherbauer, R. Windhager, 2018, Molecular and cellular probes.

M. Hacker, S. Rasul, D. Bonderman, 2022, Journal of Nuclear Cardiology.

Contemporary Management of Severe Symptomatic Aortic Stenosis.

Michail I. Papafaklis, Jeroen J. Bax, J. P. Cárdenas, 2021, Journal of the American College of Cardiology.

Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement

A. Mayr, P. Rainer, M. Hacker, 2020, Wiener klinische Wochenschrift.

Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging

G. Dorffner, M. Samwald, J. Mascherbauer, 2021, Journal of personalized medicine.

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis

C. Hengstenberg, G. Dorffner, C. Loewe, 2021, Heart.

J. Mascherbauer, D. Bonderman, C. Binder, 2018, Scientific Reports.

Modes of death in patients with heart failure and preserved ejection fraction.

J. Mascherbauer, D. Bonderman, S. Aschauer, 2017, International journal of cardiology.

Feature Tracking of Global Longitudinal Strain by Using Cardiovascular MRI Improves Risk Stratification in Heart Failure with Preserved Ejection Fraction.

C. Hengstenberg, C. Loewe, D. Beitzke, 2020, Radiology.

Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping

M. Säemann, J. Mascherbauer, M. Antlanger, 2018, Scientific Reports.

Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction.

J. Mascherbauer, D. Bonderman, C. Binder, 2017, JACC. Heart failure.

Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation

J. Mascherbauer, D. Bonderman, S. Aschauer, 2017 .

Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis

C. Hengstenberg, T. Binder, H. Agis, 2020, Clinical Research in Cardiology.

Differentiating Primary From Secondary Hypertrophy Based on the Coronary Lumen Volume to Myocardial Mass Relationship

C. Loewe, J. Mascherbauer, H. Agis, 2018 .

Fluid status and outcome in patients with heart failure and preserved ejection fraction.

M. Säemann, J. Mascherbauer, M. Hecking, 2017, International journal of cardiology.

Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction

S. Pfaffenberger, J. Mascherbauer, D. Bonderman, 2015, Journal of Cardiovascular Magnetic Resonance.

Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters

C. Hengstenberg, C. Loewe, J. Mascherbauer, 2019, European journal of clinical investigation.

Native T1 time of right ventricular insertion points by cardiac magnetic resonance: relation with invasive haemodynamics and outcome in heart failure with preserved ejection fraction.

C. Hengstenberg, C. Loewe, D. Beitzke, 2020, European heart journal cardiovascular Imaging.

Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept Study

C. Hengstenberg, G. Dorffner, M. Samwald, 2020, Journal of clinical medicine.

Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction

J. Mascherbauer, D. Bonderman, S. Aschauer, 2017, PloS one.

The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics

R. Ristl, S. Pfaffenberger, J. Mascherbauer, 2016, European journal of heart failure.

Diastolic Pressure Gradient Predicts Outcome in Patients With Heart Failure and Preserved Ejection Fraction.

J. Mascherbauer, D. Bonderman, S. Aschauer, 2015, Journal of the American College of Cardiology.

Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance

G. Maurer, R. Ristl, J. Mascherbauer, 2015, PloS one.

Prognostic Significance and Determinants of the 6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction.

R. Ristl, J. Mascherbauer, D. Bonderman, 2015, JACC. Heart failure.

Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters

M. Hacker, S. Rasul, D. Bonderman, 2022, Journal of Nuclear Cardiology.

T1-MAPPING BY CARDIAC MAGNETIC RESONANCE IMAGING: FROM HISTOLOGICAL VALIDATION TO CLINICAL IMPLICATION

A. Greiser, S. Pfaffenberger, J. Mascherbauer, 2016 .

Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.

J. Mascherbauer, D. Bonderman, S. Aschauer, 2016, Journal of the American College of Cardiology.

Determinants of Bioprosthetic Aortic Valve Degeneration.

C. Hengstenberg, D. Zimpfer, J. Mascherbauer, 2020, JACC. Cardiovascular imaging.

Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure

J. Mascherbauer, H. Agis, R. Kain, 2017, European journal of heart failure.

First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience

C. Binder-Rodriguez, H. Agis, R. Kain, 2021, ESMO open.

Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy

C. Loewe, M. Hacker, D. Beitzke, 2023, European heart journal. Cardiovascular Imaging.

Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling

J. Mascherbauer, D. Bonderman, C. Binder, 2017, Wiener klinische Wochenschrift.

Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping

M. Säemann, J. Mascherbauer, M. Antlanger, 2018, Scientific Reports.

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis

C. Hengstenberg, G. Dorffner, C. Loewe, 2021, Heart.

Contemporary Management of Severe Symptomatic Aortic Stenosis.

Michail I. Papafaklis, Jeroen J. Bax, J. P. Cárdenas, 2021, Journal of the American College of Cardiology.

Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation

C. Loewe, J. Mascherbauer, C. Doña, 2021, ESC heart failure.

What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction

C. Hengstenberg, D. Bonderman, C. Binder, 2020, Journal of clinical medicine.

J. Mascherbauer, D. Bonderman, C. Binder, 2018, Scientific Reports.

Reduction in 99mTc-DPD myocardial uptake with therapy of ATTR cardiomyopathy

C. Loewe, M. Hacker, D. Beitzke, 2023, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis.

J. Mascherbauer, H. Agis, D. Bonderman, 2018, JACC. Cardiovascular imaging.

Hepatic T1-Time Predicts Cardiovascular Risk in All-Comers Referred for Cardiovascular Magnetic Resonance: A Post-Hoc Analysis

C. Loewe, M. Trauner, D. Beitzke, 2022, Circulation. Cardiovascular imaging.

The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics

R. Ristl, S. Pfaffenberger, J. Mascherbauer, 2016, European journal of heart failure.

Right Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Cardiac Magnetic Resonance Feature Tracking and Outcomes

C. Loewe, J. Mascherbauer, C. Doña, 2023, Journal of clinical medicine.

Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy

R. Kornowski, I. Mats, P. García-Pavía, 2021, European journal of heart failure.

Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up study.

P. Agostoni, F. Duca, A. Kammerlander, 2024, Journal of cardiovascular medicine.

Association of epicardial adipose tissue on magnetic resonance imaging with cardiovascular outcomes: Quality over quantity?

J. Mascherbauer, C. Doña, F. Duca, 2023, Obesity.

Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fraction.

C. Binder-Rodriguez, C. Doña, F. Duca, 2024, European journal of internal medicine.

Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis—Insights from Histology and Cardiac Magnetic Resonance Imaging

C. Doña, F. Duca, M. Koschutnik, 2024, Journal of clinical medicine.

Cardiac Amyloidosis and Valvular Heart Disease

F. Duca, P. Bartko, C. Nitsche, 2023, Journal of clinical medicine.

DPD Quantification Correlates With Extracellular Volume and Disease Severity in Wild-Type Transthyretin Cardiac Amyloidosis

C. Doña, F. Duca, C. Nitsche, 2024, JACC. Advances.

Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study

C. Ebner, N. Verheyen, D. Bonderman, 2022, Biomedicines.

Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registry

C. Loewe, D. Beitzke, H. Agis, 2023, European heart journal. Cardiovascular Imaging.